77 related articles for article (PubMed ID: 2800566)
1. Cell-mediated immunity in patients with invasive carcinoma of the cervix.
Park TK; Kim SN
Yonsei Med J; 1989; 30(2):164-72. PubMed ID: 2800566
[TBL] [Abstract][Full Text] [Related]
2. Signaling defects and functional impairment in T-cells from cervical cancer patients.
Cheriyan VT; Krishna SM; Kumar A; Jayaprakash PG; Balaram P
Cancer Biother Radiopharm; 2009 Dec; 24(6):667-73. PubMed ID: 20025546
[TBL] [Abstract][Full Text] [Related]
3. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman J; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):997-1006. PubMed ID: 11072156
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
5. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune profile in patients with pre-cancer and cancer of the cervix: a cross sectional study among Indian women.
Gupta MM; Jain R; Parashari A; Singh V; Sharma S
Bull Cancer; 1993 Oct; 80(10):852-6. PubMed ID: 8204922
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity in cervical intraepithelial neoplasia.
Park TK; Kim SN; Choi DH; Lee CH
Asia Oceania J Obstet Gynaecol; 1992 Jun; 18(2):171-5. PubMed ID: 1503541
[TBL] [Abstract][Full Text] [Related]
8. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
[TBL] [Abstract][Full Text] [Related]
9. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
10. An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.
Garcia-Chagollan M; Jave-Suarez LF; Haramati J; Bueno-Topete MR; Aguilar-Lemarroy A; Estrada-Chavez C; Bastidas-Ramirez BE; Pereira-Suarez AL; Del Toro-Arreola S
J Biomed Sci; 2015 Oct; 22():91. PubMed ID: 26486970
[TBL] [Abstract][Full Text] [Related]
11. Production of interleukin-2 (IL-2) and expression of IL-2 receptor in patients with IgA nephropathy.
Lee TW; Kim MJ
Korean J Intern Med; 1992 Jan; 7(1):31-8. PubMed ID: 1477028
[TBL] [Abstract][Full Text] [Related]
12. Types of cell-mediated immune response in invasive zone of carcinoma of the uterine cervix.
Kozłowski H; Hrabowska M
Arch Geschwulstforsch; 1979; 49(3):240-50. PubMed ID: 496564
[No Abstract] [Full Text] [Related]
13. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
[TBL] [Abstract][Full Text] [Related]
14. Decreased natural killer cell activity in patients with invasive cervical carcinoma.
Chou CY; Hsieh CY; Hsieh KH; Chen CA
Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):128-31. PubMed ID: 2788713
[TBL] [Abstract][Full Text] [Related]
15. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
16. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
[TBL] [Abstract][Full Text] [Related]
17. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma.
Mocchegiani E; Ciavattini A; Santarelli L; Tibaldi A; Muzzioli M; Bonazzi P; Giacconi R; Fabris N; Garzetti GG
Br J Cancer; 1999 Jan; 79(2):244-50. PubMed ID: 9888464
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
19. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
20. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
